Medical/Pharmaceuticals

PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting

IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted fo...

2025-11-20 23:12 1364

Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer

* The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. * The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 cli...

2025-11-20 18:52 1277

Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong

HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients inHong Kong. The clinic is the first in the city to widely offer the ELITA™ Femtosecond Laser, the advanced system that po...

2025-11-20 17:34 1178

Smartee Deepens Its Strategy for Central Asia and Russia in 2025

SHANGHAI, Nov. 20, 2025 /PRNewswire/ -- Smartee Denti-Technology is reinforcing its international footprint with a focused strategy inCentral Asia and Russia for 2025, cementing its position as a global leader in clear aligner and digital orthodontic technologies. This year, Smartee showcased it...

2025-11-20 13:53 913

Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide

Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed * Adoption of Remplir™ among Australian urologists is accelerating, with ~100 surgeries conducted by surgeons nationwide. * This promising new applicatio...

2025-11-20 13:52 703

Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune dis...

2025-11-20 10:56 932

WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry

WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines for patients. SAN ANTONIO, Nov. 20, 2025 /PRNewswire/ -- Frost & Sullivan

2025-11-20 10:00 763

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®[1], 89Zr-DFO-girentuximab) PET/CT[2] wo...

2025-11-20 03:00 1160

NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices

WASHINGTON, Nov. 20, 2025 /PRNewswire/ -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal species, announced the results of its review of animal breeding practices inCambodia, thankingCambodia for providing extensive data and relying on science. T...

2025-11-20 01:33 958

The Rise of Advanced Maternal Age IVF: BaseCare Medical'-B(2170.HK) AI "Undisturbed Culture" Empowers Intelligent Assisted Reproduction

SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese Society of Reproductive Medicine (CSRM2025), held fromNovember 12th to 15th, indicates that the average treatment age for women undergoing IVF inChina has risen to 33.6 years, h...

2025-11-19 19:50 775

KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025

XI'AN, China, Nov. 19, 2025 /PRNewswire/ -- Shanghai Kehua Bio-engineering Co., Ltd. (KHB), a global provider of in-vitro diagnostic (IVD) solutions, is showcasing its latest compact chemiluminescence platform—the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer—at MEDICA 2025, one o...

2025-11-19 17:02 863

Older Singaporeans Support Healthier SG, but Lifestyle Habits Still Lag Behind

* New SMU research reveals critical gaps in preventive health, lifestyle habits, and continuity of care asSingapore transitions into a super-aged society. * Despite strong pro-health policies, everyday adoption - especially among older adults - remains limited. * Bridging this gap requires ...

2025-11-19 12:30 723

Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis

HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, today announced key results from its Phase II clinical trial of LNK01004, a skin restric...

2025-11-19 08:00 1026

CRScube acquires Mednet to expand global eClinical capabilities

SEOUL, South Korea and MINNEAPOLIS, Nov. 18, 2025 /PRNewswire/ -- CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North American market. The transaction unites two respected eClinical technology vendors with...

2025-11-18 17:00 915

HealthScreen Sydney Opens Australia's Most Advanced Preventative Health Facility

SYDNEY, Nov. 18, 2025 /PRNewswire/ -- HealthScreen has officially opened its new Sydney facility, expanding the organisation's preventative health and executive services following strong demand at its flagshipMelbourne centre. The new location brings together advanced multi-modal imaging, genetics...

2025-11-18 16:16 745

More countries now require tobacco plain packaging and graphic health warnings on cigarette packages

Canadian Cancer Society report highlights global progress on key tobacco control measures TORONTO, Nov. 18, 2025 /PRNewswire/ -- An international report 

2025-11-18 13:01 713

INSTITUTE OF NEURODIVERSITY, NEUROPOWER WORLD, AND SINGAPORE BRINGS NEURODESIGN TO THE FOREFRONT OF SINGAPORE'S URBAN PLANNING

Hazleen Ahmad, Founder of Neuropower World and Chair & Founder of ION Singapore, to launch pilot projects and training programmes embedding neurodesign into workplaces, housing, parks, and transport hubs SINGAPORE, Nov. 18, 2025 /PRNewswire/ -- The Institute of Neurodiversity (ION) Singapore and ...

2025-11-18 09:00 792

MindHYVE's ChironAI™ Showcased at Peshawar Institute of Cardiology's CME on Cardiovascular Imaging Innovation"

PESHAWAR, Pakistan, Nov. 18, 2025 /PRNewswire/ -- The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) hosted a high-profile Radiology Continuing Medical Education (CME) session on"Innovations in Cardiovascular Imaging," drawing senior cardiologists, radiologists, and imag...

2025-11-18 08:50 671

Genesis MedTech and National University Health System Forge Strategic Partnership to Advance AI Innovation for Safer, Smarter Surgical Care

SINGAPORE, Nov. 18, 2025 /PRNewswire/ -- Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI) in surgery and medical device innovation. This partnership stems from a Memorandum of Understanding signed ea...

2025-11-18 08:00 802

Canary Speech Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Technology Innovation Leadership

Recognized for transforming Intelligent Vocal Biomarker Diagnostics through innovative AI-powered, smartphone-based diagnostic solutions SAN ANTONIO, Nov. 17, 2025 /PRNewswire/ -- Frost & Sullivan

2025-11-17 23:00 981
1 ... 45678910 ... 397

Week's Top Stories